# A Guide To Implementing CI/CD in Your AI/ML SaMD Projects

Learn why CI/CD is crucial for AI/ML SaMD development and how you can transition your organization to CI/CD.

The number of AI-powered medical devices is rapidly increasing, with 950 AI/ML-enabled devices already authorized by the FDA. However, the journey to successfully developing and managing these complex systems remains challenging for many manufacturers. Continuous Integration/Continuous Deployment (CI/CD) is now essential for enabling AI/ML in medical software. Medical software teams can align this practice with FDA guidance to ensure product safety while accelerating development timelines.

Download the white paper to explore:

1. **Why CI/CD is crucial for AI/ML SaMD development**: Discover how CI/CD supports incremental changes, tighter feedback loops, and faster delivery of safe, reliable medical software.
2. **Challenges and Solutions**: Learn about the unique challenges of implementing CI/CD in regulated environments and the steps you can take to overcome them.
3. **Best Practices for Transitioning to CI/CD**: Get actionable insights on designing an architecture built for change, automating documentation, and maintaining end-to-end traceability.

Implementing CI/CD is now a necessity for medical device software development. Our white paper provides you with the knowledge and tools needed to make this transition seamlessly while maintaining compliance and improving product quality.